U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H20FN3O4.ClH
Molecular Weight 397.828
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OFLOXACIN HYDROCHLORIDE

SMILES

Cl.CC1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4

InChI

InChIKey=CAOOISJXWZMLBN-UHFFFAOYSA-N
InChI=1S/C18H20FN3O4.ClH/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
OFLOXACIN HYDROCHLORIDE
MART.   WHO-DD  
Common Name English
7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, 9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-, HYDROCHLORIDE
Common Name English
Ofloxacin hydrochloride [WHO-DD]
Common Name English
OFLOXACIN HYDROCHLORIDE [MART.]
Common Name English
(±)-9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, HYDROCHLORIDE
Common Name English
Code System Code Type Description
EVMPD
SUB03494MIG
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
DRUG BANK
DBSALT002388
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
FDA UNII
I2UWV315WA
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
SMS_ID
100000085916
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
PUBCHEM
189546
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
EPA CompTox
DTXSID70922609
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
CAS
118120-51-7
Created by admin on Fri Dec 15 17:53:59 UTC 2023 , Edited by admin on Fri Dec 15 17:53:59 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of OFLOXACIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966